More NewsRead More
NephroGenex, Inc. Initiates Pivotal Phase 3 Study With Novel Treatment to Slow Progression of Diabetic Kidney Disease
June 18, 2014
NephroGenex, Inc. Reports Year-End 2013 Financial Results
March 31, 2014
NephroGenex Announces Research Collaborations for Pivotal Studies of Pyridorin(TM) in Diabetic Nephropathy
March 27, 2014
NephroGenex Announces Closing of Initial Public Offering
February 14, 2014
NephroGenex, Inc (NRX) Reports Q2 Loss of $0.61/Share
August 12, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here